IVDA:NASDAQIveda Solutions, Inc. Analysis
Data as of 2026-06-14 - not real-time
$0.28
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Iveda Solutions trades at roughly $0.28, giving it a market capitalization of just over $3 million – a strikingly low valuation relative to its $5.3 million revenue base. Revenue has slumped 64% year‑over‑year and the company is operating at a -60% profit margin, with operating cash flow and free cash flow both deeply negative. Despite a cash pile of $5.15 million, the balance sheet is strained by a debt‑to‑equity ratio near 15 and a negative ROE of almost -88%, indicating limited financial flexibility. Technical indicators reinforce the downside narrative: the price sits below the 20‑day (0.324) and 50‑day (0.305) SMAs, the MACD is bearish, and RSI hovers at 40, suggesting modest weakness. Volatility is extreme at >108% over the past month, beta exceeds 2.5 in the computed data, and the stock is hovering near its $0.27 support level with $0.42 resistance.
The forward outlook shows a modestly positive EPS estimate of $1.84, translating to a forward P/E of 0.15 and a price‑to‑book of 0.35, which would appear dramatically cheap if the company could reverse its cash burn. However, the absence of any dividend, a high max drawdown of nearly 90%, and a sector (Security & Protection Services) that faces tightening regulatory scrutiny temper optimism. Given the extreme market sentiment of “Extreme Greed” but the underlying fundamentals, the stock presents a high‑risk, value‑oriented play rather than a growth opportunity.
The forward outlook shows a modestly positive EPS estimate of $1.84, translating to a forward P/E of 0.15 and a price‑to‑book of 0.35, which would appear dramatically cheap if the company could reverse its cash burn. However, the absence of any dividend, a high max drawdown of nearly 90%, and a sector (Security & Protection Services) that faces tightening regulatory scrutiny temper optimism. Given the extreme market sentiment of “Extreme Greed” but the underlying fundamentals, the stock presents a high‑risk, value‑oriented play rather than a growth opportunity.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below all major moving averages and bearish MACD
- Severe revenue decline and negative operating margins
- Extreme short‑term volatility and proximity to support level
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward EPS estimate suggests potential upside if turnaround succeeds
- Cash reserves may sustain operations through short‑term restructuring
- High debt‑to‑equity and ongoing cash burn limit confidence
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Large addressable market for AI‑driven surveillance and IoT solutions
- Execution risk remains high given historic losses and regulatory exposure
- Valuation remains deeply discounted relative to book and sales metrics
Key Metrics & Analysis
Financial Health
Revenue Growth-64.10%
Profit Margin-60.57%
P/E Ratio0.2
ROE-87.80%
ROA-34.75%
Debt/Equity14.84
P/B Ratio0.3
Op. Cash Flow$-2027501
Free Cash Flow$-919520
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI40.0
Support$0.27
Resistance$0.42
MA 20$0.32
MA 50$0.31
MA 200$0.78
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta2.61
Volatility108.03%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.